The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline/Tesaro; Roche
Research Funding - AstraZeneca; Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline/Tesaro; Roche
Health-related quality of life (QoL) in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD), a multicenter single-arm phase II clinical trial (ROLANDO, GEICO-1601).
 
José Alejandro Perez-Fidalgo
Consulting or Advisory Role - Ability Pharma; Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Novartis; PharmaMar; Roche
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - Not especified; Not especified (Inst)
Expert Testimony - Samsung Bioepis
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Alfonso Cortés Salgado
No Relationships to Disclose
 
Yolanda García
No Relationships to Disclose
 
María Iglesias
Honoraria - AstraZeneca; Clovis Oncology; Dabchi; GlaxoSmithKline; Roche
Consulting or Advisory Role - GlaxoSmithKline; Roche
Speakers' Bureau - Clovis Oncology; Dabchi; GlaxoSmithKline
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Novartis; Roche
 
Uriel Bohn Sarmiento
No Relationships to Disclose
 
Elisa Calvo García
No Relationships to Disclose
 
Luis Manso Sánchez
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Tesaro
Travel, Accommodations, Expenses - MSD Oncology; Novartis; Roche/Genentech; Tesaro
 
Ana Santaballa
No Relationships to Disclose
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Deciphera; Genmab; GlaxoSmithKline; Immunogen; Mersana; PharmaMar; Roche; Tesaro
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Amgen (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Clovis Oncology (Inst); Eisai (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
Andrés Redondo
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Research Funding - Eisai (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar
 
María Jesus Rubio
No Relationships to Disclose
 
Antonio González-Martín
No Relationships to Disclose